Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis

References

• Chaudhry V, Bastawrous A. Idiopathic pruritus ani. Semin Colon Rectal Surg. 2003;14:196–202.
   Google Scholar
• Hanno R, Murphy P. Pruritus ani. Classification and management. Dermatol Clin. 1987;5:811–816.
   Google Scholar
• Daniel GL, Longo WE, Vernava AM. Pruruitus ani. Causes and concerns. Dis Colon Rectum. 1994;37:670–674.
   Google Scholar
• Öztaş MO, Öztaş P, Önder M. Idiopathic perianal pruritus: washing compared with topical corticosteroids. Postgrad Med J. 2004;80:295–297.
   Google Scholar
• Odom RB, James WD, Berger TB. Pruritus and neurocutaneous dermatoses. In Odom RB, James WD, Berger TB, editor. Andrew's diseases of the skin. 9th ed. Philadelphia: Saunders, 2000. p 49–68.
   Google Scholar
• Johnson RA. Diseases and disorders of the anogenitalia of males. In Freedberg IM, Eisen AZ, Wolff K, et al. editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: Mc Graw-Hill, 1999. p 1348–1376.
   Google Scholar
• Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlledtrial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus study group. J Allergy Clin Immunol. 1998;102:637–644.
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44–47.
   Google Scholar
• Hanifin J, Thurston M, Omoto M, Cherill R, Tofte SC, Graeber M. The eczema and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 1998;10:11–18.
   Google Scholar
• Finlay AY, Khan GK. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
   PubMed Web of Science ®Google Scholar
• Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45:1300–1307.
   PubMed Web of Science ®Google Scholar
• Smith LE, Henrichs D, McCullah RD. Prospective studies on the etiology and treatment of puritus ani. Dis Colon Rectum. 1982;25:358–363.
   PubMed Web of Science ®Google Scholar
• Seok-gyu S, Soung-Ho K. Pruritus Ani. J Korean Soc Coloproctol. 2011;27:54–57.
   Google Scholar
• Weichert GE. An approach to the treatment of anogenital pruritus. Dermatol Ther. 2004;17:129–133.
   PubMedGoogle Scholar
• Sauer T. The role of the bidet in pruritus ani. Aust Fam Physician. 2010;39:715.
   Google Scholar
• Friend WG. The cause and treatment of idiopathic pruritus ani. Dis Colon Rectum. 1977;20:40–42.
   PubMed Web of Science ®Google Scholar
• Al-ghnaniem R, Short K, Pullen A, Fuller LC, Rennie JA, Leather AJ. 1% hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial. Int J Colorectal Dis. 2007;22:1463–1467.
   Google Scholar
• Habif TP. Topical therapy and topical corticosteroids. Clinical dermatology. 3rd ed. Missouri: Mosby, 1996. p 25–44.
   Google Scholar
• Lysy J, Sistiery-Ittah M, Israelit Y, Shmueli A, Strauss-Liviatan N, Mindrul V. Topical capsaisin- a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut. 2003;52:1323–1326.
   Google Scholar
• Etter L, Myers SA. Pruritus in systemic disease: mechanism and management. Dermatol Clin. 2002;20:249–272.
   Google Scholar
• Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–547.
   PubMed Web of Science ®Google Scholar
• Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol. 1998;8:299–306.
   PubMedGoogle Scholar
• Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neorophysiology of pruritus: cuteneous elicitation of itch. Arch Dermatol. 2003;139:1463–1470.
   PubMedGoogle Scholar
• Ruzicka T, Assmann T, Lebwohl M. Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol. 2003;13:331–342.
   Google Scholar
• Ständer S, Ständer H, Seeliger S, Luger TA, Steinhoff M. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol. 2007;156:1020–1026.
   PubMed Web of Science ®Google Scholar
• Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs. 2005;65:827–858.
   PubMed Web of Science ®Google Scholar
• Panhans-Gross A, Novak N, Kraft S, Bieber T. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol. 2001;107:345–352.
   PubMedGoogle Scholar
• Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 2001;107:519–525.
   PubMed Web of Science ®Google Scholar
• de Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol. 1992;99:723–728.
   PubMed Web of Science ®Google Scholar
• Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, et al. For the European Tacrolimus Ointment Study Group. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol. 2000;136:999–1006.
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I - efficacy. J Am Acad Dermatol. 2001;44:S28–S38.
   Google Scholar
• Reitamo S, van Leent EJM, Ho V, Harper J, Ruzicka T, Kalimo K, et al. For the European/Canadian Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002;109:539–546.
   PubMed Web of Science ®Google Scholar
• Schauber L, Weisenseel P, Ruzicka T. Topical treatment of perianal eczema with tacrolimus 0.1%. Br j Dermatol. 2009;161:1384–1386.
   Google Scholar
• Suys E. Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani. J Am Acad Dermatol. 2012;66:327–328.
   Google Scholar